NPI: 1356720023 · NORTH LAS VEGAS, NV 89030 · 261QE0700X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27,631 | $405K |
| 2019 | 47,420 | $642K |
| 2020 | 49,721 | $720K |
| 2021 | 58,428 | $774K |
| 2022 | 50,523 | $787K |
| 2023 | 28,309 | $834K |
| 2024 | 11,475 | $759K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 88,809 | 4,026 | $4.91M | |
| J1756 | Iron sucrose injection | 24,663 | 2,948 | $3K |
| Q4081 | Epoetin alfa, 100 units esrd | 78,282 | 2,339 | $2K |
| J1270 | Injection, doxercalciferol | 41,323 | 2,029 | $1K |
| A4657 | Syringe w/wo needle | 8,490 | 2,607 | $918.16 |
| 90661 | 13 | 12 | $36.85 | |
| G0008 | Admin influenza virus vac | 235 | 106 | $32.37 |
| 90674 | 127 | 59 | $25.17 | |
| 85048 | 5,723 | 2,098 | $0.00 | |
| 83540 | 3,163 | 1,108 | $0.00 | |
| 83970 | 4,935 | 1,819 | $0.00 | |
| 82108 | 1,911 | 716 | $0.00 | |
| 85041 | 5,825 | 2,138 | $0.00 | |
| J0887 | Epoetin beta esrd use | 2,279 | 476 | $0.00 |
| 83550 | 2,026 | 895 | $0.00 | |
| G0499 | Hepb screen high risk indiv | 1,771 | 476 | $0.00 |
| 82728 | 2,605 | 938 | $0.00 | |
| 82306 | 898 | 333 | $0.00 | |
| 82746 | 429 | 167 | $0.00 |